Cargando…
Estimating the infection burden of COVID-19 in Malaysia
Malaysia has reported 2.75 million cases and 31,485 deaths as of 30 December 2021. Underestimation remains an issue due to the underdiagnosis of mild and asymptomatic cases. We aimed to estimate the burden of COVID-19 cases in Malaysia based on an adjusted case fatality rate (aCFR). Data on reported...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642899/ https://www.ncbi.nlm.nih.gov/pubmed/36346816 http://dx.doi.org/10.1371/journal.pntd.0010887 |
_version_ | 1784826410474405888 |
---|---|
author | Jayaraj, Vivek Jason Ng, Chiu-Wan Bulgiba, Awang Appannan, Maheshwara Rao Rampal, Sanjay |
author_facet | Jayaraj, Vivek Jason Ng, Chiu-Wan Bulgiba, Awang Appannan, Maheshwara Rao Rampal, Sanjay |
author_sort | Jayaraj, Vivek Jason |
collection | PubMed |
description | Malaysia has reported 2.75 million cases and 31,485 deaths as of 30 December 2021. Underestimation remains an issue due to the underdiagnosis of mild and asymptomatic cases. We aimed to estimate the burden of COVID-19 cases in Malaysia based on an adjusted case fatality rate (aCFR). Data on reported cases and mortalities were collated from the Ministry of Health official GitHub between 1 March 2020 and 30 December 2021. We estimated the total and age-stratified monthly incidence rates, mortality rates, and aCFR. Estimated new infections were inferred from the age-stratified aCFR. The total estimated infections between 1 March 2020 and 30 December 2021 was 9,955,000-cases (95% CI: 6,626,000–18,985,000). The proportion of COVID-19 infections in ages 0–11, 12–17, 18–50, 51–65, and above 65 years were 19.9% (n = 1,982,000), 2.4% (n = 236,000), 66.1% (n = 6,577,000), 9.1% (n = 901,000), 2.6% (n = 256,000), respectively. Approximately 32.8% of the total population in Malaysia was estimated to have been infected with COVID-19 by the end of December 2021. These estimations highlight a more accurate infection burden in Malaysia. It provides the first national-level prevalence estimates in Malaysia that adjusted for underdiagnosis. Naturally acquired community immunity has increased, but approximately 68.1% of the population remains susceptible. Population estimates of the infection burden are critical to determine the need for booster doses and calibration of public health measures. |
format | Online Article Text |
id | pubmed-9642899 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-96428992022-11-15 Estimating the infection burden of COVID-19 in Malaysia Jayaraj, Vivek Jason Ng, Chiu-Wan Bulgiba, Awang Appannan, Maheshwara Rao Rampal, Sanjay PLoS Negl Trop Dis Research Article Malaysia has reported 2.75 million cases and 31,485 deaths as of 30 December 2021. Underestimation remains an issue due to the underdiagnosis of mild and asymptomatic cases. We aimed to estimate the burden of COVID-19 cases in Malaysia based on an adjusted case fatality rate (aCFR). Data on reported cases and mortalities were collated from the Ministry of Health official GitHub between 1 March 2020 and 30 December 2021. We estimated the total and age-stratified monthly incidence rates, mortality rates, and aCFR. Estimated new infections were inferred from the age-stratified aCFR. The total estimated infections between 1 March 2020 and 30 December 2021 was 9,955,000-cases (95% CI: 6,626,000–18,985,000). The proportion of COVID-19 infections in ages 0–11, 12–17, 18–50, 51–65, and above 65 years were 19.9% (n = 1,982,000), 2.4% (n = 236,000), 66.1% (n = 6,577,000), 9.1% (n = 901,000), 2.6% (n = 256,000), respectively. Approximately 32.8% of the total population in Malaysia was estimated to have been infected with COVID-19 by the end of December 2021. These estimations highlight a more accurate infection burden in Malaysia. It provides the first national-level prevalence estimates in Malaysia that adjusted for underdiagnosis. Naturally acquired community immunity has increased, but approximately 68.1% of the population remains susceptible. Population estimates of the infection burden are critical to determine the need for booster doses and calibration of public health measures. Public Library of Science 2022-11-08 /pmc/articles/PMC9642899/ /pubmed/36346816 http://dx.doi.org/10.1371/journal.pntd.0010887 Text en © 2022 Jayaraj et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Jayaraj, Vivek Jason Ng, Chiu-Wan Bulgiba, Awang Appannan, Maheshwara Rao Rampal, Sanjay Estimating the infection burden of COVID-19 in Malaysia |
title | Estimating the infection burden of COVID-19 in Malaysia |
title_full | Estimating the infection burden of COVID-19 in Malaysia |
title_fullStr | Estimating the infection burden of COVID-19 in Malaysia |
title_full_unstemmed | Estimating the infection burden of COVID-19 in Malaysia |
title_short | Estimating the infection burden of COVID-19 in Malaysia |
title_sort | estimating the infection burden of covid-19 in malaysia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642899/ https://www.ncbi.nlm.nih.gov/pubmed/36346816 http://dx.doi.org/10.1371/journal.pntd.0010887 |
work_keys_str_mv | AT jayarajvivekjason estimatingtheinfectionburdenofcovid19inmalaysia AT ngchiuwan estimatingtheinfectionburdenofcovid19inmalaysia AT bulgibaawang estimatingtheinfectionburdenofcovid19inmalaysia AT appannanmaheshwararao estimatingtheinfectionburdenofcovid19inmalaysia AT rampalsanjay estimatingtheinfectionburdenofcovid19inmalaysia |